Tag: CBL-514

All

Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction

Participants experienced an average reduction of 28.1% of subcutaneous fat volume compared with placebo.

All

Sorry, No Posts Found

All

FDA Clears Expanded Indications for Swift Microwave Wart Device

New data show the Swift system reduces blistering, discomfort, and recovery time while maintaining strong clinical outcomes for common and plantar warts.

Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends
Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E
FDA Warns Websites Over Unapproved Botox Products

Tag: CBL-514

All

Investigational Injectable Drug Demonstrates Efficacy in Localized Fat Reduction

All

Sorry, No Posts Found

All

FDA Clears Expanded Indications for Swift Microwave Wart Device

Regenerative and Personalized Care Lead 2026 Facial Plastic Surgery Trends

Allergan Aesthetics to Present Phase 3 Data for First-in-Class Botulinum Neurotoxin E

FDA Warns Websites Over Unapproved Botox Products

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links